低剂量德克萨米他对实验性肺结核的作用
Jacqueline V Lara-Espinosa1, María Fernanda Arce-Aceves2, Jorge Barrios-Payán1
1Sección de Patología Experimental, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Domínguez Sección 16, Tlalpan, Mexico City 14080, Mexico.
Microorganisms
|June 28, 2023
概括
低剂量德克萨米他治疗对结核病 (TB) 有希望. 这种治疗减少了细菌负荷,肺炎,并改善了小鼠的生存率,为对抗这种致命的细菌疾病提供了潜在的新方法.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 仍然是全球主要的死亡原因.
- 葡萄糖皮质类药物 (GCs) 通常抑制炎症,但也可以表现出促炎作用.
- 全球结核细胞的双重作用要求对结核病等传染病进行调查.
研究的目的:
- 评估低剂量德克萨米他作为结核病辅助治疗的疗效.
- 调查德克萨米他对Mycobacterium结核病 (Mtb) 感染的体内和体外影响.
主要方法:
- 在体内研究中建立了进展性结核病的小鼠模型.
- 在晚期结核病患者中,用抗生素给予内内或鼻内德克萨米他.
- 在实验室研究中,使用感染Mtb.的小鼠膜巨细胞进行了实验.
主要成果:
- 德克萨米他降低了小鼠的肺菌负荷,肺炎和疾病行为.
- 治疗增加了动物的生存率,并减少了中枢神经系统 (CNS) 的炎症.
- 在体外,德克萨米他增强了Mtb清除,调节了细胞因子表达,并在巨细胞中诱导了亡.
结论:
- 低剂量德克萨米他显示出作为肺结核有效辅助治疗的潜力.
- 这些发现表明,通过调节宿主免疫反应来管理结核病的新型治疗策略.
更多相关视频
相关概念视频
Pulmonary Tuberculosis I
286
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
286
Pulmonary Tuberculosis II
281
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
281
Pulmonary Tuberculosis V
214
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
214
Pulmonary Tuberculosis IV
175
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
175
Pulmonary Tuberculosis III
381
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
381


